# Ammar Hemaidan – FDA Inspection, Jul 21, 2017

Source: https://www.keypedia.com/records/fda_inspections/ammar-hemaidan/389ce53c-938f-4b2a-be1e-2bde98a3519f
Source feed: FDA_Inspections

> FDA inspection 1020931 of Ammar Hemaidan, July 21, 2017. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 312. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1020931
- Company Name: Ammar Hemaidan
- Inspection Date: 2017-07-21
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Officers

- [Investigator](https://www.keypedia.com/people/richard-w-berning/4637e321-8803-4fcf-911f-bbc810c3487d)

Company: https://www.keypedia.com/companies/ammar-hemaidan/509b111f-4b54-4dbc-9873-95772f159183

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c